IE 11 is not supported. For an optimal experience visit our site on another browser.

Avastin could buy time in battle with ovarian cancer


Two studies out Wednesday show that Avastin, a drug that is already approved for other cancers -- but is also controversial -- could help women buy more time in the battle with ovarian cancer. More from NBC's Chief Science Correspondent Robert Bazell.